Cargando…
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550958/ https://www.ncbi.nlm.nih.gov/pubmed/33833386 http://dx.doi.org/10.1038/s41375-021-01232-2 |
| _version_ | 1784591065682018304 |
|---|---|
| author | Tambaro, Francesco Paolo Singh, Harjeet Jones, Emily Rytting, Michael Mahadeo, Kris M. Thompson, Philip Daver, Naval DiNardo, Courtney Kadia, Tapan Garcia-Manero, Guillermo Chan, Tim Shah, Rutul R. Wierda, William G. |
| author_facet | Tambaro, Francesco Paolo Singh, Harjeet Jones, Emily Rytting, Michael Mahadeo, Kris M. Thompson, Philip Daver, Naval DiNardo, Courtney Kadia, Tapan Garcia-Manero, Guillermo Chan, Tim Shah, Rutul R. Wierda, William G. |
| author_sort | Tambaro, Francesco Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8550958 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85509582021-11-10 Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia Tambaro, Francesco Paolo Singh, Harjeet Jones, Emily Rytting, Michael Mahadeo, Kris M. Thompson, Philip Daver, Naval DiNardo, Courtney Kadia, Tapan Garcia-Manero, Guillermo Chan, Tim Shah, Rutul R. Wierda, William G. Leukemia Letter Nature Publishing Group UK 2021-04-08 2021 /pmc/articles/PMC8550958/ /pubmed/33833386 http://dx.doi.org/10.1038/s41375-021-01232-2 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Tambaro, Francesco Paolo Singh, Harjeet Jones, Emily Rytting, Michael Mahadeo, Kris M. Thompson, Philip Daver, Naval DiNardo, Courtney Kadia, Tapan Garcia-Manero, Guillermo Chan, Tim Shah, Rutul R. Wierda, William G. Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title | Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title_full | Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title_fullStr | Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title_full_unstemmed | Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title_short | Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia |
| title_sort | autologous cd33-car-t cells for treatment of relapsed/refractory acute myelogenous leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550958/ https://www.ncbi.nlm.nih.gov/pubmed/33833386 http://dx.doi.org/10.1038/s41375-021-01232-2 |
| work_keys_str_mv | AT tambarofrancescopaolo autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT singhharjeet autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT jonesemily autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT ryttingmichael autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT mahadeokrism autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT thompsonphilip autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT davernaval autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT dinardocourtney autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT kadiatapan autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT garciamaneroguillermo autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT chantim autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT shahrutulr autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia AT wierdawilliamg autologouscd33cartcellsfortreatmentofrelapsedrefractoryacutemyelogenousleukemia |